CSL Behring Medical Expert Portal is a European webpage designed for healthcare professionals (HCPs) who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available. If you are interested in the relevant content for a specific country, please refer to the CSL Behring affiliate in your country to obtain relevant information. The medical and scientific information provided on this website is for informational purposes only and should not replace professional advice from a healthcare provider in your area. It is important that you always adhere to the regulations and guidelines relevant to your country.

Disclaimer: Due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.

Disclaimer

CSL EXPERT HIVE

Expert views

Long-term prophylaxis with pdVWF/FVIII concentrate in a ratio of 2.4:1 for VWD

Pathology:

Von Willebrand Disease

Speakers: Günter Auerswald and Will Thomas

In this video, Günter Auerswald and Will Thomas, two of the authors of a recently published systematic literature review summarising the efficacy and safety of plasma-derived von Willebrand Factor and Factor VIII concentrate (pdVWF/FVIII) in a ratio of 2.4:1 in von Willebrand disease (VWD), present the reported outcomes of studies investigating the safety and efficacy of pdVWF/FVIII concentrate in a ratio of 2.4:1 for long-term prophylaxis in VWD.